The US Food and Drug Administration replaced its medical-device cybersecurity guidance in February 2026, updating recommendations tied to statutory duties that took effect in 2023. Taiwan's regulator publishes a 2021 lifecycle guide and five reference templates, but the cited public material does not establish a US-style statutory submission rule.
INTERPOL and the United Nations Office on Drugs and Crime warned on March 17, 2026, that generative AI was making trusted-person impersonation easier. A familiar voice or face can now support a false request, so money and data should move only after a separate identity check.
National Taiwan University Hospital said in 2026 that it had built a federated-learning platform with partner hospitals to validate medical AI without moving their data off site. The approach limits centralized data collection, but it does not eliminate privacy, performance or accountability risks.
More than 20,000 people had signed a petition by August 6 urging Kmart to withdraw its sold-out Anko camera glasses in Australia. The A$89 device can record hands-free, while its small indicator may give bystanders little practical notice.
Taiwan added 17 smart assistive products to a long-term-care rental benefit on July 1, 2026. The published list identifies products and suppliers but does not provide performance metrics or explain how each system makes decisions.
Coinkite warned on July 30, 2026, that seeds created by several Coldcard models on affected firmware may be exposed because seed generation used a general-purpose pseudorandom generator. A build integration error silently routed the process away from the hardware random-number generator without stopping the firmware build.
A July 30, 2026 Coldcard advisory showed how a random-number integration error could remain hidden while security-sensitive outputs still looked valid. The same failure pattern matters in health information systems that generate pseudonyms and SMART on FHIR authorization secrets.
A coalition of US state attorneys general reportedly opened an investigation into OpenAI on June 12, 2026, seeking records on advertising, data practices and vulnerable users. The subpoena arrived four days after OpenAI disclosed a confidential draft S-1, but neither the filing nor the subpoena is public.
International guidance gives health organizations a practical set of controls to test before deploying generative AI. The work starts with data handling and audit design, then extends to source traceability, human authority and continuous monitoring.
Taiwan Health Nexus began operations on January 9, 2026, with plans to connect health records held by separate institutions for AI and research. Its public claims address interoperability, but evidence on consent, oversight and commercial reuse remains limited.
Former BrewDog shareholders have complained to the United Kingdom’s privacy regulator after James Watt contacted them about his bid to buy back the brewer. Watt says the data was obtained lawfully, while owner Tilray says it neither supplied the shareholder records nor helped with the messages.
